Profile data is unavailable for this security.
About the company
Uni-Bio Science Group Limited is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company operates through four segments. In-house Chemical Pharmaceutical Products segment is engaged in the manufacture and sales of in-house chemical pharmaceutical products. Its chemical pharmaceutical products include Pinapu, among others. In-house Biological Pharmaceutical Products segment is engaged in the manufacture and sales of in-house biological pharmaceutical products. Its biological pharmaceutical products include GeneTime and GeneSoft, among others. In-house Biological Pipeline segment is engaged in the industrialization of in-house biological pipeline. Its biological pipeline products include Uni-E4 and Uni-PTH, among others. Third-party Pharmaceutical Products segment is engaged in the sales of third-party pharmaceutical products.
- Revenue in HKD (TTM)484.72m
- Net income in HKD70.88m
- Incorporated2001
- Employees407.00
- LocationUni-Bio Science Group Ltd13/F, Public Bank Centre,120 Des Voeux Road Central, Central Hong KongHKG
- Phone+852 31023232
- Fax+852 31023737
- Websitehttps://www.uni-bioscience.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China NT Pharma Group Co Ltd | 7.95m | -36.16m | 81.87m | 16.00 | -- | -- | -- | 10.30 | -0.1828 | -0.7836 | 0.0377 | -1.39 | 0.011 | 5.87 | 0.337 | 497,008.90 | -5.02 | -12.34 | -- | -163.52 | 710.06 | -- | -454.67 | -128.28 | 0.0185 | -- | 64.15 | -- | -- | -58.12 | 33.07 | -- | -46.32 | -- |
| Extrawell Pharmaceutical Holdings Ltd | 59.10m | -162.95m | 83.65m | 159.00 | -- | 0.0752 | -- | 1.42 | -0.0682 | -0.0682 | 0.0247 | 0.4657 | 0.0433 | 5.90 | 11.81 | 371,685.50 | -11.83 | 1.01 | -12.32 | 1.06 | 48.70 | 50.54 | -273.51 | 18.00 | 3.31 | -0.0554 | 0.0977 | -- | -18.57 | -7.91 | -226.06 | -- | -- | -- |
| Regent Pacific Group Ltd | 2.47m | -195.54m | 94.80m | 17.00 | -- | -- | -- | 38.31 | -0.8685 | -0.8685 | 0.011 | -0.053 | 0.0218 | -- | 12.19 | 145,566.40 | -172.08 | -50.00 | -694.26 | -59.04 | -- | -- | -7,901.89 | -2,685.21 | -- | -- | -- | -- | 574.47 | -44.72 | 31.24 | -- | -50.60 | -- |
| Canbridge Pharmaceuticals Inc | 111.06m | -408.98m | 150.82m | 100.00 | -- | -- | -- | 1.36 | -0.9638 | -0.9638 | 0.2617 | -0.1012 | 0.1875 | 4.16 | 4.09 | 1,110,569.00 | -69.04 | -- | -154.20 | -- | 62.37 | -- | -368.26 | -- | 0.6132 | -41.34 | 1.39 | -- | 30.26 | -- | 21.64 | -- | -- | -- |
| Kontafarma China Holdings Ltd | 809.11m | -28.84m | 184.42m | 720.00 | -- | 0.1744 | 4.17 | 0.2279 | -0.0052 | -0.0052 | 0.145 | 0.1892 | 0.4206 | 3.22 | 7.03 | 1,123,760.00 | -3.18 | -1.33 | -4.22 | -2.18 | 58.25 | 54.70 | -7.55 | -4.12 | 1.28 | -17.16 | 0.2392 | -- | -9.50 | -17.32 | 66.02 | -- | -19.55 | -- |
| Modern Chinese Medicine Group Co Ltd | 371.45m | 52.68m | 204.00m | 191.00 | 3.87 | 0.3996 | 3.44 | 0.5492 | 0.0878 | 0.0878 | 0.6191 | 0.8509 | 0.6681 | 5.45 | 3.80 | 1,944,788.00 | 9.47 | 20.76 | 10.75 | 25.82 | 30.28 | 41.02 | 14.18 | 20.11 | 7.98 | 206.12 | 0.0002 | 2.54 | -13.91 | 14.67 | -44.44 | 0.2303 | 96.96 | -- |
| Shenzhen Neptunus Intrlng Bi tchnq CoLtd | 1.13bn | 29.32m | 243.31m | 1.44k | 8.30 | -- | 11.12 | 0.2156 | 0.0175 | 0.0175 | 0.6726 | -- | -- | -- | -- | 781,623.60 | -- | 3.46 | -- | 5.13 | 39.48 | 49.14 | 1.46 | 4.29 | -- | 109.94 | -- | 0.00 | 7.92 | 4.19 | -55.60 | -12.89 | -11.10 | -- |
| PuraPharm Corp Ltd | 406.86m | -106.08m | 277.13m | 662.00 | -- | 1.81 | -- | 0.6811 | -0.2685 | -0.2685 | 1.03 | 0.3871 | 0.4374 | 1.04 | 4.21 | 614,590.60 | -11.40 | -9.20 | -34.00 | -19.70 | 53.24 | 59.52 | -26.07 | -19.33 | 0.3046 | -2.02 | 0.7349 | -- | -9.20 | -11.41 | 11.76 | -- | -13.68 | -- |
| Hin Sang Group (Interntnl) Hldng Co Ltd | 92.62m | -36.71m | 300.24m | 265.00 | -- | 1.44 | -- | 3.24 | -0.0336 | -0.0336 | 0.0848 | 0.1913 | 0.1536 | 2.34 | 8.44 | -- | -6.04 | -5.11 | -9.78 | -7.04 | 61.98 | 59.72 | -39.30 | -28.42 | 0.1287 | -1.81 | 0.6054 | -- | 13.70 | -12.83 | 25.84 | -- | -- | -- |
| Uni-Bio Science Group Ltd | 484.72m | 70.88m | 351.32m | 407.00 | 5.12 | 1.39 | 4.00 | 0.7248 | 0.0111 | 0.0111 | 0.0762 | 0.041 | 1.38 | 2.62 | 13.50 | 1,190,953.00 | 20.18 | 1.46 | 28.50 | 1.97 | 81.04 | 80.59 | 14.62 | 1.23 | 1.76 | 97.93 | 0.1796 | 0.00 | 10.08 | 29.08 | 84.04 | -- | 84.98 | -- |
| Wai Yuen Tong Medicine Holdings Limited | 783.88m | -26.68m | 388.16m | 810.00 | -- | 0.2913 | 4.74 | 0.4952 | -0.0228 | -0.0132 | 0.6636 | 1.18 | 0.1721 | 0.4001 | 10.55 | 967,754.30 | -0.1597 | -0.3053 | -0.2538 | -0.5206 | 50.37 | 43.82 | -0.928 | -2.18 | 1.37 | 2.13 | 0.2879 | -- | 8.33 | 0.8488 | -62.16 | -- | 15.35 | -- |
